2-(3,5-Dichloro-4-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

ETHYL 5-AMINO-6-BROMOPYRAZINE-2-CARBOXYLATE, 95%, 10g

N,N'-Diethyl-1,6-diaminohexane>97.0%(GC)(T)25mL

(S)-N4-(3-Chloro-4-fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine, 95.0%, 100g

diethyl[(oxiran-2-yl)methyl]amine, 95.0%, 10g

7-Chloroisoquinolin-8-amine, 97%, 250mg

2-BOC-8-AMINO-5-OXA-2-AZASPIRO[3.4]OCTANE, 95.0%, 100mg

Alizarin complexone dihydrate, min. 97%, pa, 1 g, glass packaging

1-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-4-YL)AMINO)-3,6,9,12,15-PENTAOXAOCTADECAN-18-OIC ACID, 95%, 50mg

Dimethyl 2,2-diisobutylmalonate, 97.0%, 50g

4-(5-Bromo-2-chlorobenzyl)phenol, 95.0%, 250mg

Z-Ala-Gly-OH, 96.0%, 25g

(4-Hydroxy-3,5-dimethoxybenzylidene)malononitrile, 1g